Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lantos Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
Lantos Technologies

Lantos Technologies

Lantos Technologies: FDA-cleared developer of 3D ear scanning systems for custom medical products.

HQ
Wilmington, MA, US
Founded
2009
Overview
Compare
Fundraising
Employees

Lantos Technologies is dedicated to revolutionizing medical imaging with its FDA-cleared 3D ear scanning systems. These systems enable the creation of custom in-ear products, enhancing precision and comfort for users. The company focuses on the medical market, particularly audiology and hearing aid sectors, providing innovative solutions for personalized healthcare.

Lantos Technologies has achieved significant milestones, including FDA clearance for its 3D ear scanning technology, which underscores its commitment to quality and innovation. This breakthrough has positioned the company as a leader in the medical imaging field, impacting the way custom in-ear products are designed and fitted.

Lantos Technologies - Similar Companies

Wavs Custom logo

Wavs Custom

wavscustom.com

PionEar Technologies logo

PionEar Technologies

pionear-tech.com

XinVivo logo

XinVivo

xinvivo.com

Cactus Medical logo

Cactus Medical

Earlens logo

Earlens

earlenscorp.com

OtoNexus Medical Technologies logo

OtoNexus Medical Technologies

otonexus.com

Otologic Technologies logo

Otologic Technologies

otologictech.com

Preceptis Medical logo

Preceptis Medical

Fit3D logo

Fit3D

fit3d.com

Intelon Optics logo

Intelon Optics

SoundFit logo

SoundFit

Dalent Medical logo

Dalent Medical

dalentmedical.com

Delphinus Medical Technologies logo

Delphinus Medical Technologies

delphinusmt.com

Lumedica logo

Lumedica

Lumafield logo

Lumafield

lumafield.com

Lantos Technologies - Quick Facts

Who are Lantos Technologies' competitors?

Companies similar to Lantos Technologies include Wavs Custom, PionEar Technologies, XinVivo and Cactus Medical.

When was Lantos Technologies founded?

Lantos Technologies was founded in 2009.

Where is Lantos Technologies' headquarters located?

Lantos Technologies' headquarters is located in Wilmington, MA, US.

When was Lantos Technologies' last funding round?

Lantos Technologies' most recent funding round was for $3.9M (USD) in November 2020.

How much has Lantos Technologies raised to-date?

As of Nov 24, 2020, Lantos Technologies has raised a total of $31.8M (USD).

How many employees does Lantos Technologies have?

Lantos Technologies has 36 employees as of Feb 5, 2024.

Lantos Technologies - Classification

Industry
  • Hardware
Ownership
  • Equity
  • Venture Capital
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • 3D Scanning
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified